{"id":"https://openalex.org/W4380680324","doi":"https://doi.org/10.1161/circ.146.suppl_1.11565","title":"Abstract 11565: Improvement in Cardiopulmonary Function in a Rat Model of Pulmonary Arterial Hypertension Observed With RKER-012, a Novel Activin Receptor Type II Ligand Trap, was Associated With Reduced Markers of Inflammation and Fibrosis in the Right Ventricle","display_name":"Abstract 11565: Improvement in Cardiopulmonary Function in a Rat Model of Pulmonary Arterial Hypertension Observed With RKER-012, a Novel Activin Receptor Type II Ligand Trap, was Associated With Reduced Markers of Inflammation and Fibrosis in the Right Ventricle","publication_year":2022,"publication_date":"2022-11-08","ids":{"openalex":"https://openalex.org/W4380680324","doi":"https://doi.org/10.1161/circ.146.suppl_1.11565"},"language":"en","primary_location":{"id":"doi:10.1161/circ.146.suppl_1.11565","doi":"https://doi.org/10.1161/circ.146.suppl_1.11565","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1161/circ.146.suppl_1.11565","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084213970","display_name":"Chris Materna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259476","display_name":"Keros Therapeutics (United States)","ror":"https://ror.org/029wzgz47","country_code":"US","type":"company","lineage":["https://openalex.org/I4405259476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris Materna","raw_affiliation_strings":["Keros Therapeutics, Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keros Therapeutics, Lexington, MA","institution_ids":["https://openalex.org/I4405259476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073738534","display_name":"R.K. Babbs","orcid":"https://orcid.org/0000-0001-9547-7722","observed_orcids":["https://orcid.org/0000-0001-9547-7722"]},"institutions":[{"id":"https://openalex.org/I4405259476","display_name":"Keros Therapeutics (United States)","ror":"https://ror.org/029wzgz47","country_code":"US","type":"company","lineage":["https://openalex.org/I4405259476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith Babbs","raw_affiliation_strings":["Keros Therapeutics, Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keros Therapeutics, Lexington, MA","institution_ids":["https://openalex.org/I4405259476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084890905","display_name":"Nathan O. Kaplan","orcid":"https://orcid.org/0000-0001-5305-983X","observed_orcids":["https://orcid.org/0000-0001-5305-983X"]},"institutions":[{"id":"https://openalex.org/I4405259476","display_name":"Keros Therapeutics (United States)","ror":"https://ror.org/029wzgz47","country_code":"US","type":"company","lineage":["https://openalex.org/I4405259476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathan Kaplan","raw_affiliation_strings":["Keros Therapeutics, Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keros Therapeutics, Lexington, MA","institution_ids":["https://openalex.org/I4405259476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111903892","display_name":"Ffolliott Fisher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259476","display_name":"Keros Therapeutics (United States)","ror":"https://ror.org/029wzgz47","country_code":"US","type":"company","lineage":["https://openalex.org/I4405259476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"ffolliott Fisher","raw_affiliation_strings":["Keros Therapeutics, Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keros Therapeutics, Lexington, MA","institution_ids":["https://openalex.org/I4405259476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052288239","display_name":"Jasbir S. Seehra","orcid":"https://orcid.org/0009-0002-0843-8974","observed_orcids":["https://orcid.org/0009-0002-0843-8974"]},"institutions":[{"id":"https://openalex.org/I4405259476","display_name":"Keros Therapeutics (United States)","ror":"https://ror.org/029wzgz47","country_code":"US","type":"company","lineage":["https://openalex.org/I4405259476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jasbir Seehra","raw_affiliation_strings":["Keros Therapeutics, Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keros Therapeutics, Lexington, MA","institution_ids":["https://openalex.org/I4405259476"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041514565","display_name":"Jennifer L. Lachey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259476","display_name":"Keros Therapeutics (United States)","ror":"https://ror.org/029wzgz47","country_code":"US","type":"company","lineage":["https://openalex.org/I4405259476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Lachey","raw_affiliation_strings":["Keros Therapeutics, Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keros Therapeutics, Lexington, MA","institution_ids":["https://openalex.org/I4405259476"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405259476"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"146","issue":"Suppl_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pulmonary-arterial-hypertension","display_name":"pulmonary arterial hypertension","score":0.9990000128746033},{"id":"https://openalex.org/keywords/smad2-3-signaling","display_name":"Smad2/3 signaling","score":0.9259999990463257},{"id":"https://openalex.org/keywords/tgf-beta-signaling","display_name":"TGF-beta signaling","score":0.8149999976158142},{"id":"https://openalex.org/keywords/right-ventricular-remodeling","display_name":"right ventricular remodeling","score":0.8949999809265137},{"id":"https://openalex.org/keywords/pulmonary-fibrosis","display_name":"pulmonary fibrosis","score":0.7879999876022339},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.6240000128746033},{"id":"https://openalex.org/keywords/sugen-hypoxia-model","display_name":"Sugen/hypoxia model","score":0.8429999947547913},{"id":"https://openalex.org/keywords/pulmonary-vascular-resistance","display_name":"pulmonary vascular resistance","score":0.5860000252723694},{"id":"https://openalex.org/keywords/right-ventricular-hypertrophy","display_name":"right ventricular hypertrophy","score":0.6169999837875366},{"id":"https://openalex.org/keywords/timp-1","display_name":"TIMP-1","score":0.5989999771118164},{"id":"https://openalex.org/keywords/collagen-expression","display_name":"collagen expression","score":0.5740000009536743},{"id":"https://openalex.org/keywords/lox","display_name":"LOX","score":0.5920000076293945},{"id":"https://openalex.org/keywords/runx2","display_name":"Runx2","score":0.7590000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8747338056564331},{"id":"https://openalex.org/C2780930700","wikidata":"https://www.wikidata.org/wiki/Q1128595","display_name":"Pulmonary hypertension","level":2,"score":0.6576305627822876},{"id":"https://openalex.org/C2778921608","wikidata":"https://www.wikidata.org/wiki/Q2002035","display_name":"Ventricle","level":2,"score":0.6087492108345032},{"id":"https://openalex.org/C2778271984","wikidata":"https://www.wikidata.org/wiki/Q17126794","display_name":"Pressure overload","level":4,"score":0.5838425755500793},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5494673252105713},{"id":"https://openalex.org/C7836513","wikidata":"https://www.wikidata.org/wiki/Q1641506","display_name":"Hypoxia (environmental)","level":3,"score":0.5079823136329651},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.5055155754089355},{"id":"https://openalex.org/C58245268","wikidata":"https://www.wikidata.org/wiki/Q456026","display_name":"Vascular resistance","level":3,"score":0.45736604928970337},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.4430004954338074},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.44253015518188477},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.3781208395957947},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.3029043674468994},{"id":"https://openalex.org/C540031477","wikidata":"https://www.wikidata.org/wiki/Q629","display_name":"Oxygen","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C3018791406","wikidata":"https://www.wikidata.org/wiki/Q945225","display_name":"Cardiac hypertrophy","level":3,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1161/circ.146.suppl_1.11565","doi":"https://doi.org/10.1161/circ.146.suppl_1.11565","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1161/circ.146.suppl_1.11565","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8399999737739563,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4403812894","https://openalex.org/W3217160923","https://openalex.org/W4410271604","https://openalex.org/W4388871496","https://openalex.org/W4396500160","https://openalex.org/W4247692102","https://openalex.org/W4281476798","https://openalex.org/W4387543091","https://openalex.org/W3130470571","https://openalex.org/W7165808323"],"abstract_inverted_index":{"Pulmonary":[0],"arterial":[1,158],"hypertension":[2],"(PAH)":[3],"is":[4,20,32,84],"characterized":[5],"by":[6,27],"elevated":[7,28],"pulmonary":[8,157,200],"vascular":[9],"resistance,":[10],"impaired":[11],"cardiac":[12,109,198],"output,":[13],"and":[14,36,66,161,187,199,242,258,268,306,314,324],"right":[15],"ventricle":[16],"(RV)":[17],"overload.":[18],"PAH":[19,72,115,311],"associated":[21,33],"with":[22,34,195],"imbalanced":[23],"TGF-\u00df":[24],"signaling,":[25,30],"marked":[26],"SMAD2/3":[29],"which":[31,76],"inflammation":[35,305],"fibrosis":[37,307],"contributing":[38],"to":[39,51,60,97,173,192,203,226,263,277,287],"heart":[40],"failure.":[41],"Initially,":[42],"the":[43,80,175],"RV":[44,62,169,231],"can":[45],"compensate":[46],"for":[47,71,332],"increased":[48,185,207,210,230,273],"pressure":[49,57,159],"due":[50],"its":[52],"adaptive":[53],"contractility,":[54],"but":[55,289],"chronic":[56],"overload":[58],"leads":[59],"maladaptive":[61],"remodeling":[63],"through":[64,100],"inflammatory":[65],"fibrotic":[67,234],"pathways.":[68],"Current":[69],"therapies":[70],"are":[73],"primarily":[74],"vasodilators":[75],"do":[77],"not":[78,221,293],"treat":[79],"underlying":[81],"pathology.":[82],"RKER-012":[83,142,178,205,300],"a":[85,112,119,310,319,329],"research":[86],"form":[87],"of":[88,106,108,123,168,177,197,233,253,303],"KER-012,":[89],"an":[90],"investigational":[91],"modified":[92],"ActRIIB":[93],"ligand":[94],"trap":[95],"designed":[96],"inhibit":[98],"signaling":[99],"SMAD2/3.":[101],"We":[102],"investigated":[103],"RKER-012\u2019s":[104],"mechanism":[105,176,321],"prevention":[107],"pathology":[110],"in":[111,153,179,214,274,283,309],"Sugen/Hypoxia":[113],"(SH)":[114],"model.":[116,181],"Rats":[117],"received":[118,136,149],"subcutaneous":[120],"(SQ)":[121],"dose":[122],"25":[124],"mg/kg":[125,141],"Sugen":[126],"5416":[127],"under":[128],"hypoxic":[129],"conditions.":[130,155],"For":[131],"3":[132],"weeks,":[133],"SH":[134,215],"rats":[135,148,183,216,249],"vehicle":[137],"(SH-VEH)":[138],"or":[139],"10":[140],"(SH-RKER-012)":[143],"twice":[144,151],"weekly":[145,152],"SQ.":[146],"Control":[147],"VEH":[150],"normoxic":[154],"Systolic":[156],"(sPAP)":[160],"Fulton":[162],"index":[163],"(FI)":[164],"were":[165,272],"measured.":[166],"qPCR":[167],"tissue":[170],"was":[171,281,292],"used":[172],"evaluate":[174],"this":[180],"SH-VEH":[182,228,275],"had":[184,229,250],"FI":[186],"sPAP":[188,211,219],"(both":[189,212,270],"p\u22640.0001)":[190],"compared":[191,276,286],"NX,":[193,227],"consistent":[194],"development":[196],"impairment.":[201],"Relative":[202,225],"SH-VEH,":[204],"reduced":[206,251,282],"FIand":[208],"prevented":[209],"p\u22640.001)":[213],"so":[217],"that":[218,299,316],"did":[220],"differ":[222],"from":[223,322],"NX.":[224,278],"expression":[232,252,280,291],"markers":[235,266,308],"such":[236],"as":[237,328],"Timp1,":[238,254],"Col1a1,":[239,255],"Col3a1,":[240,256],"Runx2,":[241],"LOX":[243,259],"(all":[244,260],"p\u22640.05).":[245],"In":[246],"contrast,":[247],"SH-RKER-012":[248,284],"Runx2":[257],"p\u22640.05)":[261,271],"relative":[262],"SH-VEH.":[264],"Inflammation":[265],"CD68":[267,279],"MCP1":[269,290],"(p\u22640.01)":[285],"NX":[288],"affected":[294],"(p=0.54).":[295],"These":[296],"results":[297],"support":[298],"attenuated":[301],"upregulation":[302],"key":[304],"preclinical":[312],"model":[313],"suggest":[315],"KER-012":[317],"has":[318],"distinct":[320],"vasodilation":[323],"could":[325],"be":[326],"developed":[327],"cardioprotective":[330],"treatment":[331],"PAH.":[333]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2023-06-15T00:00:00"}